A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial)
Year: 2019
Type: article
Study design: Clinical Trial
Institutions: Hanyang University Seoul Hospital, Hanyang University, Samsung Medical Center, Sungkyunkwan University, Asan Medical Center, University of Ulsan, Chonnam National University Hwasun Hospital, Inje University Busan Paik Hospital, Keimyung University Dongsan Medical Center, Keimyung University Dongsan Hospital, Keimyung University, Seoul National University, Soonchunhyang University, Yeungnam University College, Yeungnam University, Ulsan University Hospital, Yonsei University, The Catholic University of Korea St. Vincent's Hospital, Catholic University of Korea, Korea Institute of Radiological and Medical Sciences
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2960979804